Since the Nkx2-3 mutation affects mostly the B lymphocyte development and recirculation, we hypothesized that the activation of B cells might be impaired, which, in turn, led to ameliorated arthritis. The gene discussed is NKX2-3; the disease is arthritic joint disease.